NYSE$PHR
Phreesia Inc · Q4 2024 earnings
Q4 2024 earnings · · Investor relations
Briefing
Phreesia reported strong momentum going into fiscal year 2025.
Phreesia announced its Q4 Fiscal Year 2024 results, with total revenue reaching $95.0 million, a 24% increase year-over-year. The company facilitated over 150 million patient visits in fiscal 2024 and is focusing on continued growth and a return to profitability.
- Total revenue was $95.0 million, up 24% year-over-year.
- Average number of healthcare services clients (AHSCs) was 3,962, up 26% year-over-year.
- Healthcare services revenue per AHSC was $17,456, down 1% year-over-year.
- Net loss was $30.6 million, compared to $38.0 million in the same period in the prior year.
Headline financials
Revenue & EPS history
Phreesia · Revenue · Quarterly
$95M
Revenue by segment
Phreesia · $91.6M total across 3 segments · Q3 2024
- Subscription Services$42.6M+29.1%46.5%
- Network Solutions$25.8M+26.0%28.2%
- Payment Processing$23.2M+18.3%25.3%
Forward guidance
Phreesia is maintaining its revenue outlook for fiscal year 2025 at a range of $424 million to $434 million, implying year-over-year growth of 19% to 22%. The company is updating its Adjusted EBITDA outlook for fiscal year 2025 to a range of $12 million to $20 million from a previous range of $10 million to $20 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q4 2024
-1.6%
Avg return
Earnings day
+2.5%
Avg return
5 days after
+2.0%
Avg return
30 days after
54%
15 / 28 earnings
Positive
+21.4%
Q2 2023
Best reaction
-26.3%
Q4 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -26.3% | -1.1% | — | |
| Q1 2027 | +2.3% | +13.3% | — | |
| Q3 2026 | -22.8% | -19.2% | -16.0% | |
| Q2 2026 | -9.8% | -18.8% | -25.4% | |
| Q1 2026 | -6.6% | -0.2% | +14.2% | |
| Q4 2025 | +6.9% | +14.6% | +1.1% | |
| Q3 2025 | +11.1% | +14.8% | +30.8% | |
| Q2 2025 | +7.9% | +0.5% | -6.8% | |
| Q1 2025 | -13.3% | -14.7% | -2.9% | |
| Q4 2024 | +1.7% | -0.7% | +1.0% | |
| Q3 2024 | +17.8% | +18.8% | +45.2% | |
| Q2 2024 | -21.2% | -27.1% | -39.1% | |
| Q1 2024 | +3.6% | +10.3% | +4.0% | |
| Q4 2023 | -13.5% | -10.0% | -5.7% | |
| Q3 2023 | +18.7% | +34.8% | +20.0% | |
| Q2 2023 | +21.4% | +28.2% | +4.9% | |
| Q1 2023 | +11.9% | +17.5% | +40.1% | |
| Q4 2022 | -11.9% | +1.3% | -23.6% | |
| Q3 2022 | -20.2% | -20.9% | -32.9% | |
| Q2 2022 | -12.4% | -6.2% | -15.4% | |
| Q1 2022 | +6.6% | +12.7% | +24.2% | |
| Q4 2021 | +2.5% | +8.4% | +3.3% | |
| Q3 2021 | +7.3% | +18.1% | +16.2% | |
| Q2 2021 | -3.2% | -9.2% | +3.5% | |
| Q1 2021 | -6.7% | -10.5% | -13.1% | |
| Q4 2020 | +4.2% | +18.1% | +30.6% | |
| Q3 2020 | -1.0% | -8.8% | -6.9% | |
| Q2 2020 | +0.2% | +7.3% | +1.2% | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro